{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:14:12Z","timestamp":1783710852362,"version":"3.55.0"},"reference-count":89,"publisher":"Xia & He Publishing","issue":"000","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"DOI":"10.14218\/jcth.2021.00001","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:55:20Z","timestamp":1620946520000},"page":"000-000","source":"Crossref","is-referenced-by-count":2,"title":["Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review"],"prefix":"10.14218","volume":"000","author":[{"given":"Deepak","family":"Madhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop","family":"Saraya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5334","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J Med Virol"},{"issue":"8","key":"key20210513225515_JCTH-D-21-00001-b2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"key20210513225515_JCTH-D-21-00001-b3","unstructured":"World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b5","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"key":"key20210513225515_JCTH-D-21-00001-b6","unstructured":"World Health Organization. WHO Coronavirus disease (COVID-19) dashboard. Available from: https:\/\/covid19.who.int\/"},{"key":"key20210513225515_JCTH-D-21-00001-b7","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2217\/fmb-2020-0110","article-title":"Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)","volume":"15","author":"Kordzadeh-Kermani","year":"2020","journal-title":"Future Microbiol"},{"issue":"10","key":"key20210513225515_JCTH-D-21-00001-b8","first-page":"e10923","article-title":"COVID-19-induced hepatic injury: A systematic review and meta-analysis","volume":"12","author":"Abdulla","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b9","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.31472","article-title":"Elevated liver biochemistries in hospitalized chinese patients with severe COVID-19: Systematic review and meta-analysis","volume":"73","author":"Kovalic","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b10","first-page":"292","article-title":"Positive association between severity of COVID-19 infection and liver damage: a systematic review and meta-analysis","volume":"13","author":"Shokri Afra","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.15916","article-title":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19","volume":"52","author":"Kulkarni","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","article-title":"SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19","volume":"73","author":"Wang","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b13","first-page":"282","article-title":"Increased inflammatory markers correlate with liver damage and predict severe COVID-19: a systematic review and meta-analysis","volume":"13","author":"Amiri-Dashatan","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"key20210513225515_JCTH-D-21-00001-b14","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31684","article-title":"Liver disease and COVID-19: from Pathogenesis to Clinical Care","author":"Saviano","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/hepr.13577","article-title":"Association of coagulopathy with liver dysfunction in patients with COVID-19","volume":"51","author":"Tsutsumi","year":"2021","journal-title":"Hepatol Res"},{"key":"key20210513225515_JCTH-D-21-00001-b16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.humpath.2020.11.015","article-title":"Pathological findings in the postmortem liver of patients with coronavirus disease 2019 (COVID-19)","volume":"109","author":"Zhao","year":"2021","journal-title":"Hum Pathol"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12072-020-10071-9","article-title":"Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis","volume":"14","author":"Kumar-M","year":"2020","journal-title":"Hepatol Int"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12072-020-10078-2","article-title":"Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis","volume":"14","author":"Kovalic","year":"2020","journal-title":"Hepatol Int"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"issue":"6220","key":"key20210513225515_JCTH-D-21-00001-b20","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"23","key":"key20210513225515_JCTH-D-21-00001-b21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5694\/mja2.50674","article-title":"COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS","volume":"213","author":"Gibson","year":"2020","journal-title":"Med J Aust"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b23","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1213\/ANE.0000000000005062","article-title":"Hypotension, systemic inflammatory response syndrome, and COVID-19: A clinical conundrum","volume":"131","author":"Hanidziar","year":"2020","journal-title":"Anesth Analg"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41392-020-00373-7","article-title":"COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms","volume":"5","author":"Zhong","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"key20210513225515_JCTH-D-21-00001-b25","unstructured":"Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and research information on drug-induced liver injury. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548196\/"},{"issue":"7","key":"key20210513225515_JCTH-D-21-00001-b26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40264-020-00954-z","article-title":"Drug-induced liver injury and COVID-19 infection: The rules remain the same","volume":"43","author":"Olry","year":"2020","journal-title":"Drug Saf"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tcm.2020.12.004","article-title":"COVID-19 and thrombosis: From bench to bedside","volume":"31","author":"Ali","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/apt.12592","article-title":"Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis","volume":"39","author":"Czaja","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s12072-020-10084-4","article-title":"Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis","volume":"14","author":"Grace","year":"2020","journal-title":"Hepatol Int"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12664-020-01074-3","article-title":"Poor outcomes in patients with cirrhosis and Corona Virus Disease-19","volume":"39","author":"Shalimar, Elhence","year":"2020","journal-title":"Indian J Gastroenterol"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b31","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12072-020-10072-8","article-title":"Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)","volume":"14","author":"Sarin","year":"2020","journal-title":"Hepatol Int"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"J Hepatol"},{"key":"key20210513225515_JCTH-D-21-00001-b33","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31797","article-title":"Outcome of COVID-19 in patients with autoimmune hepatitis: an international multi-centre study","author":"Efe","year":"2021","journal-title":"Hepatology"},{"key":"key20210513225515_JCTH-D-21-00001-b34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-CoV-2 infection in patients with autoimmune hepatitis","author":"Marjot","year":"2021","journal-title":"J Hepatol"},{"key":"key20210513225515_JCTH-D-21-00001-b35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3389\/fphar.2020.01333","article-title":"Immunosuppressive drugs and COVID-19: A review","volume":"11","author":"Schoot","year":"2020","journal-title":"Front Pharmacol"},{"issue":"6","key":"key20210513225515_JCTH-D-21-00001-b36","doi-asserted-by":"crossref","first-page":"e13404","DOI":"10.1111\/tid.13404","article-title":"SARS-CoV2 and immunosuppression: A double-edged sword","volume":"22","author":"Lai","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virusres.2012.02.002","article-title":"Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506","volume":"165","author":"Carbajo-Lozoya","year":"2012","journal-title":"Virus Res"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b38","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/v5051250","article-title":"Suppression of coronavirus replication by cyclophilin inhibitors","volume":"5","author":"Tanaka","year":"2013","journal-title":"Viruses"},{"issue":"10","key":"key20210513225515_JCTH-D-21-00001-b39","doi-asserted-by":"crossref","first-page":"e1002331","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog"},{"issue":"13","key":"key20210513225515_JCTH-D-21-00001-b40","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"key20210513225515_JCTH-D-21-00001-b41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b42","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen","year":"2020","journal-title":"Crit Care"},{"key":"key20210513225515_JCTH-D-21-00001-b43","doi-asserted-by":"crossref","first-page":"117230","DOI":"10.1016\/j.jns.2020.117230","article-title":"Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic","volume":"420","author":"Kovvuru","year":"2021","journal-title":"J Neurol Sci"},{"issue":"10","key":"key20210513225515_JCTH-D-21-00001-b44","doi-asserted-by":"crossref","first-page":"e13319","DOI":"10.1111\/eci.13319","article-title":"Bloodstream infections in critically ill patients with COVID-19","volume":"50","author":"Giacobbe","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"key20210513225515_JCTH-D-21-00001-b45","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3389\/fphar.2020.01198","article-title":"Corticosteroid use in the treatment of COVID-19: A multicenter retrospective study in Hunan, China","volume":"11","author":"Ma","year":"2020","journal-title":"Front Pharmacol"},{"issue":"13","key":"key20210513225515_JCTH-D-21-00001-b46","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: A randomized clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"key20210513225515_JCTH-D-21-00001-b47","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): A randomized, double-blind, phase iib, placebo-controlled trial","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"13","key":"key20210513225515_JCTH-D-21-00001-b48","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10047-019-01138-y","article-title":"The incidence, risk factors, and outcomes of gastrointestinal bleeding in patients with a left ventricular assist device: a Japanese single-center cohort study","volume":"23","author":"Akiyama","year":"2020","journal-title":"J Artif Organs"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jhep.2020.08.035","article-title":"Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium","volume":"74","author":"Verhelst","year":"2021","journal-title":"J Hepatol"},{"issue":"10","key":"key20210513225515_JCTH-D-21-00001-b51","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.cgh.2020.05.047","article-title":"Rates of symptomatic SARS-CoV-2 infection in patients with autoimmune liver diseases in northern Italy: A telemedicine study","volume":"18","author":"Rigamonti","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b52","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2020.05.008","article-title":"Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy","volume":"73","author":"Di Giorgio","year":"2020","journal-title":"J Hepatol"},{"issue":"9","key":"key20210513225515_JCTH-D-21-00001-b53","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients","volume":"4","author":"Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b55","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12072-020-10054-w","article-title":"Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations","volume":"14","author":"Lau","year":"2020","journal-title":"Hepatol Int"},{"issue":"SI-1","key":"key20210513225515_JCTH-D-21-00001-b56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3906\/sag-2004-146","article-title":"COVID-19: Prevention and control measures in community","volume":"50","author":"G\u00fcner","year":"2020","journal-title":"Turk J Med Sci"},{"issue":"9-S","key":"key20210513225515_JCTH-D-21-00001-b57","first-page":"50","article-title":"COVID-19 and healthcare facilities: a decalogue of design strategies for resilient hospitals","volume":"91","author":"Capolongo","year":"2020","journal-title":"Acta Biomed"},{"issue":"6","key":"key20210513225515_JCTH-D-21-00001-b58","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/SLA.0000000000004455","article-title":"Results of COVID-minimal surgical pathway during surge-phase of COVID-19 pandemic","volume":"272","author":"Boffa","year":"2020","journal-title":"Ann Surg"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.shaw.2020.03.001","article-title":"Preventing intra-hospital infection and transmission of coronavirus disease 2019 in health-care workers","volume":"11","author":"Gan","year":"2020","journal-title":"Saf Health Work"},{"issue":"12","key":"key20210513225515_JCTH-D-21-00001-b60","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1080\/17474124.2020.1822734","article-title":"Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic","volume":"14","author":"Efe","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"key20210513225515_JCTH-D-21-00001-b61","unstructured":"CravenJCOVID-19 vaccine tracker. Available from: https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker"},{"key":"key20210513225515_JCTH-D-21-00001-b62","unstructured":"World Health Organization. Draft landscape of COVID-19 candidate vaccines. Available from: https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines"},{"key":"key20210513225515_JCTH-D-21-00001-b63","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31751","article-title":"AASLD expert panel consensus statement: Vaccines to prevent COVID-19 infection in patients with liver disease","author":"Fix","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"key20210513225515_JCTH-D-21-00001-b64","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.transproceed.2012.05.071","article-title":"Response to vaccination against hepatitis B virus with a schedule of four 40-\u00b5g doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response","volume":"44","author":"Gutierrez Domingo","year":"2012","journal-title":"Transplant Proc"},{"issue":"Suppl 5","key":"key20210513225515_JCTH-D-21-00001-b65","doi-asserted-by":"crossref","first-page":"B33","DOI":"10.1016\/S0264-410X(02)00510-8","article-title":"Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis","volume":"20","author":"Gaeta","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/jhep.2001.25883","article-title":"Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients","volume":"34","author":"Arguedas","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b68","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","author":"W\u00f6rns","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"key20210513225515_JCTH-D-21-00001-b69","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b70","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients","volume":"74","author":"Cornberg","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"key20210513225515_JCTH-D-21-00001-b71","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","article-title":"Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"key20210513225515_JCTH-D-21-00001-b72","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"Robert-Guroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b73","doi-asserted-by":"crossref","first-page":"100169","DOI":"10.1016\/j.jhepr.2020.100169","article-title":"Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic","volume":"2","author":"Boettler","year":"2020","journal-title":"JHEP Rep"},{"key":"key20210513225515_JCTH-D-21-00001-b74","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"key20210513225515_JCTH-D-21-00001-b75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"issue":"7806","key":"key20210513225515_JCTH-D-21-00001-b76","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b78","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b79","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gutjnl-2020-322539","article-title":"Effect of IBD medications on COVID-19 outcomes: results from an international registry","volume":"70","author":"Ungaro","year":"2021","journal-title":"Gut"},{"issue":"1","key":"key20210513225515_JCTH-D-21-00001-b80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol"},{"issue":"7","key":"key20210513225515_JCTH-D-21-00001-b81","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3390\/microorganisms8070977","article-title":"Calcineurin inhibitor-based immunosuppression and COVID-19: Results from a multidisciplinary cohort of patients in northern Italy","volume":"8","author":"Cavagna","year":"2020","journal-title":"Microorganisms"},{"issue":"11","key":"key20210513225515_JCTH-D-21-00001-b82","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/S2665-9913(20)30309-X","article-title":"Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment","volume":"2","author":"Robinson","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"key20210513225515_JCTH-D-21-00001-b83","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"key20210513225515_JCTH-D-21-00001-b84","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"key20210513225515_JCTH-D-21-00001-b85","doi-asserted-by":"crossref","first-page":"e589","DOI":"10.1016\/S2665-9913(20)30270-8","article-title":"B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?","volume":"2","author":"Mehta","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"12","key":"key20210513225515_JCTH-D-21-00001-b86","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00296-020-04699-x","article-title":"High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study","volume":"40","author":"Loarce-Martos","year":"2020","journal-title":"Rheumatol Int"},{"key":"key20210513225515_JCTH-D-21-00001-b87","doi-asserted-by":"crossref","first-page":"109897","DOI":"10.1016\/j.mehy.2020.109897","article-title":"Ursodeoxycholic acid as a candidate therapeutic to alleviate and\/or prevent COVID-19-associated cytokine storm","volume":"143","author":"Abdulrab","year":"2020","journal-title":"Med Hypotheses"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b88","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12072-020-10041-1","article-title":"Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI)","volume":"14","author":"Saigal","year":"2020","journal-title":"Hepatol Int"},{"issue":"4","key":"key20210513225515_JCTH-D-21-00001-b89","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/FTD.0000000000000766","article-title":"Important interactions of immunosuppressants with experimental therapies for novel coronavirus disease (COVID-19): How to act","volume":"42","author":"Zijp","year":"2020","journal-title":"Ther Drug Monit"}],"container-title":["Journal of Clinical and Translational Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:19:52Z","timestamp":1783707592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.xiahepublishing.com\/2310-8819\/JCTH-2021-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":89,"journal-issue":{"issue":"000","published-online":{"date-parts":[[2021,5,14]]},"published-print":{"date-parts":[[2021,5,14]]}},"alternative-id":["10.14218\/JCTH.2021.00001"],"URL":"https:\/\/doi.org\/10.14218\/jcth.2021.00001","relation":{},"ISSN":["2225-0719","2310-8819"],"issn-type":[{"value":"2225-0719","type":"print"},{"value":"2310-8819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]}}}